SCHEMBL6172286

SCHEMBL6172286

Cc1cccc2c(C(C)C3NC(=O)N(c4ccc(OC(F)(F)F)cc4)C3=O)ccnc12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
MAPK7 Q13164 1/20 0.39
POLB P06746 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GPR139 Q6DWJ6 3/20 0.34
TRPV4 Q9HBA0 1/20 0.33
CASR P41180 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
PDE2A O00408 1/20 0.33
SLC40A1 Q9NP59 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
MCHR1 Q99705 3/20 0.33
HRH4 Q9H3N8 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA3 P34903 1/20 0.32
CXCR3 P49682 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171030 0.91 LMNA (0.40) LMNAPOLBL3MBTL1GPR139TRPV4
SCHEMBL6174955 0.91 LMNA (0.40) LMNAPOLBL3MBTL1GPR139TRPV4
SCHEMBL6171217 0.90 GPR139 (0.43) LMNAGPR139
SCHEMBL6175890 0.89 LMNA (0.39) LMNAPOLBL3MBTL1GPR139TRPV4
SCHEMBL6172559 0.86 LMNA (0.37) LMNAMAPK7POLBL3MBTL1GPR139
SCHEMBL6175238 0.84 IGF1R (0.43) LMNAPOLBL3MBTL1NPSR1ALDH1A1
SCHEMBL6173959 0.80 LMNA (0.40) LMNAPOLBL3MBTL1TRPV4MCHR1
SCHEMBL6174388 0.79 MAPK7 (0.39) MAPK7POLBL3MBTL1GPR139TRPV4
SCHEMBL6173698 0.77 LMNA (0.42) LMNAPOLBL3MBTL1PDE2AMCHR1
SCHEMBL6171781 0.77 P2RX3 (0.36) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed